Novel inhibitors of HSV-1 protease effective in vitro and in vivo
Magdalena Pachota(Jagiellonian University), Krzysztof Pyrć(Jagiellonian University), Renata Grzywa(Wrocław University of Science and Technology), Aleksandra Synowiec(Jagiellonian University), Marcin Skoreński(Wrocław University of Science and Technology), Karolina Kamińska(Wrocław University of Science and Technology), Ewa Bielecka(Jagiellonian University), Krzysztof Szczubiałka(Jagiellonian University), Marcin Sieńczyk(Wrocław University of Science and Technology), Maria Nowakowska(Jagiellonian University), Jakub Iwanejko(Wrocław University of Science and Technology), Dominika Iwan(Wrocław University of Science and Technology), Elżbieta Wojaczyńska(Wrocław University of Science and Technology), Cameron D. Mackereth(Centre National de la Recherche Scientifique)
Cited by 11
Related Papers
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): a Systemic Infection
|Clinical Microbiology Reviews|2021|219
APOBEC3-mediated restriction of RNA virus replication
|Scientific Reports|2018|129
HTCC as a Polymeric Inhibitor of SARS-CoV-2 and MERS-CoV
|Journal of Virology|2020|102
Acriflavine, a clinically approved drug, inhibits SARS-CoV-2 and other betacoronaviruses
|Cell chemical biology|2022|61
Feline herpesvirus 1 (FHV-1) enters the cell by receptor-mediated endocytosis
|Journal of Virology|2023|52